Neoadjuvant capecitabine and oxaliplatin (CAPOX) followed by chemoradiation (CRT) in high-risk rectal cancer: A single-institution experience.
Saif Ahmad
No relevant relationships to disclose
Deepak Parashar
No relevant relationships to disclose
Catherine Rachel Jephcott
No relevant relationships to disclose
Hugo Ford
Consultant or Advisory Role - Roche
Honoraria - Roche/Genentech
Other Remuneration - Roche/Genentech
Charles Wilson
Disclosure not yet available